Table 3 Estimates of externally age-standardised 10-year relative survival (RS) in percentages, loss in life expectancy (LLE) in years and proportion of life lost (PLL) in percentages in the absence of screening as well as in the presence of screening across different screening sensitivities and attendance scenarios
From: Assessing lead time bias due to mammography screening on estimates of loss in life expectancy
Attendance | Screening | 10-Year RS | LLE | PLL |
|---|---|---|---|---|
— | None | 50.96 (48.18–54.04) | 8.08 (7.62–8.50) | 44.13 (41.58–46.39) |
Perfect | Low | 52.35 (49.36–55.44) | 7.80 (7.37–8.20) | 42.95 (40.56–45.13) |
Perfect | Moderate | 53.47 (50.72–55.91) | 7.63 (7.24–8.00) | 42.18 (39.95–44.21) |
Perfect | High | 54.81 (52.27–57.50) | 7.48 (7.08–7.89) | 41.47 (39.29–43.73) |
Imperfect | Low | 52.05 (49.29–54.91) | 7.87 (7.45–8.29) | 43.22 (40.84–45.56) |
Imperfect | Moderate | 52.83 (49.69–55.65) | 7.74 (7.33–8.16) | 42.69 (40.37–44.95) |
Imperfect | High | 53.83 (51.24–56.47) | 7.63 (7.20–8.07) | 42.16 (39.88–44.65) |